High density mapping in valvular heart disease
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0003349
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 200
1) Patients with age between 19-80 years
2) Patients with moderate to severe valvular heart disease (aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid stenosis and tricuspid regurgitation) or patients with prior valve surgery with/without surgical maze operation
3) Documented atrial arrhythmias (atrial flutter or tachycardia) or Documented atrial fibrillation refractory/intolerant to class I or III antriarrhytmic drug
Patients refusing participation in the registry
Age< 18 years old or > 80 years old
pregnant woman
Presence of atrial septal defect or patent foramen ovale closure device
Presence of intracardiac thrombus
NYHA functional class IV heart failure
Acute coronary syndrome within 1 months
Planned open heart surgery within 3 months
Prior open heart surgery within 3 months
Life expectancy less than 1 year
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute success, defined as termination of the atrial tachyarrhythmia by ablation, and non-inducibility of any atrial tachycardia by rapid atrial pacing or isoproterenol infusion
- Secondary Outcome Measures
Name Time Method Arrhythmia recurrence during long-term follow-up